Inventor · disambiguated record
Paul Gomes
Also filed as: GOMES PAUL
9 granted patents·3 pending applications·12 citations·filing 2010–2021
85Inventor score
Top patents by PatentIndex Score
12 records- 0189US10675279B2Ophthalmic formulations of cetirizine and methods of useNICOX OPHTHALMICS INC·Filed 2018·Granted Jun 9, 2020·2 cites·8 claims
- 0283US9750684B2Ophthalmic formulations of cetirizine and methods of useACIEX THERAPEUTICS INC·Filed 2015·Granted Sep 5, 2017·3 cites·4 claims
- 0381US9993471B2Ophthalmic formulations of cetirizine and methods of useNICOX OPHTHALMICS INC·Filed 2017·Granted Jun 12, 2018·2 cites·6 claims
- 0481US9254286B2Ophthalmic formulations of cetirizine and methods of useABELSON MARK B·Filed 2010·Granted Feb 9, 2016·4 cites·3 claims
- 0577US11918573B2Ophthalmic formulations of cetirizine and methods of useNICOX OPHTHALMICS INC·Filed 2021·Granted Mar 5, 2024·0 cites·11 claims
- 0674US11617749B2Ophthalmic formulations of cetirizine and methods of useNICOX OPHTHALMICS INC·Filed 2020·Granted Apr 4, 2023·0 cites·5 claims
- 0773US10987352B2Ophthalmic formulations of cetirizine and methods of useNICOX OPHTHALMICS INC·Filed 2020·Granted Apr 27, 2021·0 cites·8 claims
- 0864US8829005B2Ophthalmic formulations of cetirizine and methods of useACIEX THERAPEUTICS INC·Filed 2013·Granted Sep 9, 2014·0 cites·8 claims
- 0963US8569273B2Ophthalmic formulations of cetirizine and methods of useABELSON MARK BARRY·Filed 2010·Granted Oct 29, 2013·1 cites·14 claims
- 1049US2014045803A1Ophthalmic Formulations Of Cetirizine And Methods Of UseACIEX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1134US2011105450A1Ophthalmic formulations of fluticasone and methods of useACIEX THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 1233US2010240624A1Ophthalmic Formulations of Ketotifen and Methods of UseACIEX THERAPEUTICS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Gomes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →